BAPTA-AM: Difference between revisions
Jump to navigation
Jump to search
imported>Kevin No edit summary |
imported>Kevin No edit summary |
||
| (One intermediate revision by the same user not shown) | |||
| Line 18: | Line 18: | ||
==References== | ==References== | ||
*[https://pubchem.ncbi.nlm.nih.gov/compound/2293 PubChem] | |||
*[http://www.xenbase.org/literature/article.do?method=display&articleId=4661 Leclerc et al., 2003] | *[http://www.xenbase.org/literature/article.do?method=display&articleId=4661 Leclerc et al., 2003] | ||
>762 Xenbase articles contain a reference to BAPTA-AM according to [http://www.xenbase.org/cgi-bin/textpresso/xenopus/search textpresso] | >762 Xenbase articles contain a reference to BAPTA-AM according to [http://www.xenbase.org/cgi-bin/textpresso/xenopus/search textpresso] | ||
* | |||
*[[Small Molecules for Xenopus Research|Back To Small Molecules Home Page]] | |||
Latest revision as of 12:28, 2 June 2015
Description
Selective calcium chelator that is the cell-permeable analog of BAPTA (Cat. No. 2786). Blocks hKv1.5, hKV11.1 (hERG) and hKv1.3 channels (Ki values are 1.23, 1.30 and 1.45 μM respectively). Displays antithrombotic activity in vitro.
Suppliers
Usage Notes
.4uM in .1x NAM
References
>762 Xenbase articles contain a reference to BAPTA-AM according to textpresso